| 中文名 | 1-(3-异丙基-[1,2,4]噁二唑-5-基)哌啶-4-醇 |
|---|---|
| 英文名 | 1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-ol |
| 中文别名 |
1-(3-异丙基-1,2,4-噁二唑-5-基)哌啶-4-醇
1-(3-异丙基-[1,2,4]恶二唑-5-基)哌啶-4-醇 |
| 英文别名 |
4-Hydroxy-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidine
4-Piperidinol, 1-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl] 1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinol 1-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-ol |
| 分子式 | C10H17N3O2 |
|---|---|
| 分子量 | 211.26100 |
| 精确质量 | 211.13200 |
| PSA | 62.39000 |
| LogP | 1.21910 |
|
~73%
832714-37-1 |
| 文献:ARENA PHARMACEUTICALS, INC. Patent: WO2005/7658 A2, 2005 ; Location in patent: Page 199-200 ; WO 2005/007658 A2 |
|
~33%
832714-37-1 |
| 文献:BRISTOL-MYERS SQUIBB COMPANY; YE, Xiang-Yang; WACKER, Dean A.; ROBL, Jeffrey A.; WANG, Ying Patent: WO2011/140160 A1, 2011 ; Location in patent: Page/Page column 129 ; WO 2011/140160 A1 |
|
~%
832714-37-1 |
| 文献:ARENA PHARMACEUTICALS, INC. Patent: WO2005/121121 A2, 2005 ; Location in patent: Page/Page column 166 ; WO 2005/121121 A2 |
|
~%
832714-37-1 |
| 文献:BRISTOL-MYERS SQUIBB COMPANY; YE, Xiang-Yang; WACKER, Dean A.; ROBL, Jeffrey A.; WANG, Ying Patent: WO2011/140160 A1, 2011 ; WO 2011/140160 A1 |